REPLIMUNE GROUP, INC.

REPL ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $234.1M

Liabilities Breakdown FY2020

Total Liabilities: $50.4M